Gadobutrol

Generic Name
Gadobutrol
Brand Names
Gadavist, Gadovist
Drug Type
Small Molecule
Chemical Formula
C18H31GdN4O9
CAS Number
770691-21-9
Unique Ingredient Identifier
1BJ477IO2L
Background

Intravenous gadobutrol is a second-generation extracellular non-ionic macrocyclic GBCA (gadolinium-based contrast agent) used in magnetic resonance imaging (MRI) in adults and children older than 2 years of age. It may help visualize and detect vascular abnormalities in the blood brain barrier (BBB) and central nervous system (CNS).
...

Indication

Gadobutrol is indicated for use with magnetic resonance imaging for the following diagnostic processes:

Associated Conditions
Arterial Occlusive Diseases of the Supra-aortic arteries, Coronary Artery Disease (CAD), Malignant Breast Neoplasm, Renal artery occlusion
Associated Therapies
-
Clinical Trials
Related News

Study to Compare MultiHance With Gadovist in Magnetic Resonance Imaging (MRI) of the Brain

Phase 4
Completed
Conditions
Brain Lesions
Interventions
Drug: GADOVIST
First Posted Date
2009-05-22
Last Posted Date
2012-01-05
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
121
Registration Number
NCT00907530
Locations
🇨🇦

Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada

Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)

First Posted Date
2008-12-08
Last Posted Date
2024-01-19
Lead Sponsor
University of California, San Francisco
Target Recruit Count
76
Registration Number
NCT00804128
Locations
🇺🇸

University of California, San Francisco, San Francisco, California, United States

Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases

First Posted Date
2006-09-13
Last Posted Date
2023-12-12
Lead Sponsor
Stanford University
Target Recruit Count
114
Registration Number
NCT00375830
Locations
🇺🇸

Stanford University School of Medicine, Stanford, California, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy